Related Experiment Videos
Risk assessment for aflatoxin: an evaluation based on the multistage model
J Bowers1, B Brown, J Springer
1U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Washington, D.C. 20204.
Summary
Aflatoxin exposure poses a significant cancer risk, especially for individuals with hepatitis B. This study quantifies aflatoxin
Area of Science:
- Toxicology and Carcinogenesis
- Environmental Health Risk Assessment
Background:
- Aflatoxins are potent carcinogens found in contaminated food.
- Hepatitis B virus infection is a major risk factor for liver cancer.
- Assessing aflatoxin's cancer risk is crucial for public health.
Purpose of the Study:
- To estimate the lifetime cancer potency of aflatoxin for the U.S. population.
- To evaluate the influence of hepatitis B virus status on aflatoxin's carcinogenic risk.
Main Methods:
- Utilized data from the Yeh et al. study conducted in China.
- Employed a biologically motivated risk assessment model.
- Measured aflatoxin exposure and hepatitis B prevalence.
Main Results:
- Estimated aflatoxin cancer potency at 9 (mg/kg/day)-1 for hepatitis B-negative individuals.
- Estimated aflatoxin cancer potency at 230 (mg/kg/day)-1 for hepatitis B-positive individuals.
- Demonstrated a significantly higher potency in the presence of hepatitis B.
Conclusions:
- Aflatoxin is a potent carcinogen, with risk amplified by hepatitis B co-infection.
- These findings are critical for informing U.S. regulatory standards and public health interventions.
- Further research may refine risk estimates for diverse populations.